These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 19279446

  • 1. Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare.
    Keller M, Lu Y, Lalonde RG, Klein MB.
    AIDS; 2009 Mar 27; 23(6):731-7. PubMed ID: 19279446
    [Abstract] [Full Text] [Related]

  • 2. Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals.
    Smith PR, Sarner L, Murphy M, James B, Thomas JM, Skinner CJ, Aitken C.
    J Clin Virol; 2003 Jan 27; 26(1):101-7. PubMed ID: 12589840
    [Abstract] [Full Text] [Related]

  • 3. Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
    Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G, CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group.
    PLoS One; 2012 Jan 27; 7(3):e32369. PubMed ID: 22412867
    [Abstract] [Full Text] [Related]

  • 4. Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.
    Ng OT, Lin L, Laeyendecker O, Quinn TC, Sun YJ, Lee CC, Leo YS.
    PLoS One; 2011 Jan 27; 6(1):e15738. PubMed ID: 21298051
    [Abstract] [Full Text] [Related]

  • 5. Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.
    Amornkul PN, Karita E, Kamali A, Rida WN, Sanders EJ, Lakhi S, Price MA, Kilembe W, Cormier E, Anzala O, Latka MH, Bekker LG, Allen SA, Gilmour J, Fast PE, IAVI Africa HIV Prevention Partnership.
    AIDS; 2013 Nov 13; 27(17):2775-86. PubMed ID: 24113395
    [Abstract] [Full Text] [Related]

  • 6. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda.
    Kiwanuka N, Robb M, Laeyendecker O, Kigozi G, Wabwire-Mangen F, Makumbi FE, Nalugoda F, Kagaayi J, Eller M, Eller LA, Serwadda D, Sewankambo NK, Reynolds SJ, Quinn TC, Gray RH, Wawer MJ, Whalen CC.
    J Acquir Immune Defic Syndr; 2010 Jun 13; 54(2):180-4. PubMed ID: 20010433
    [Abstract] [Full Text] [Related]

  • 7. African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study.
    Müller V, von Wyl V, Yerly S, Böni J, Klimkait T, Bürgisser P, Ledergerber B, Günthard HF, Bonhoeffer S, Swiss HIV Cohort Study.
    AIDS; 2009 Jun 19; 23(10):1269-76. PubMed ID: 19461503
    [Abstract] [Full Text] [Related]

  • 8. Disease progression and survival in HIV-1-infected Africans in London.
    Del Amo J, Petruckevitch A, Phillips A, Johnson AM, Stephenson J, Desmond N, Hanscheid T, Low N, Newell A, Obasi A, Paine K, Pym A, Theodore CM, De Cock KM.
    AIDS; 1998 Jul 09; 12(10):1203-9. PubMed ID: 9677170
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).
    Yebra G, Rivas P, Herrero MD, López M, de Mulder M, Puente S, Ramírez-Olivencia G, Soriano V, Holguín A.
    AIDS Res Hum Retroviruses; 2009 Jan 09; 25(1):37-44. PubMed ID: 19182919
    [Abstract] [Full Text] [Related]

  • 16. Rapid disease progression in HIV-1 subtype C-infected South African women.
    Mlisana K, Werner L, Garrett NJ, McKinnon LR, van Loggerenberg F, Passmore JA, Gray CM, Morris L, Williamson C, Abdool Karim SS, Centre for the AIDS Programme of Research in South Africa (CAPRISA) 002 Study Team.
    Clin Infect Dis; 2014 Nov 01; 59(9):1322-31. PubMed ID: 25038116
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.
    Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM, TREAT Asia Studies to Evaluate Resistance (TASER) and The TREAT Asia HIV Observational Database.
    J Acquir Immune Defic Syndr; 2013 Mar 01; 62(3):293-300. PubMed ID: 23138836
    [Abstract] [Full Text] [Related]

  • 19. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D.
    Alaeus A, Lidman K, Björkman A, Giesecke J, Albert J.
    AIDS; 1999 May 28; 13(8):901-7. PubMed ID: 10371170
    [Abstract] [Full Text] [Related]

  • 20. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.
    Geretti AM, Harrison L, Green H, Sabin C, Hill T, Fearnhill E, Pillay D, Dunn D, UK Collaborative Group on HIV Drug Resistance.
    Clin Infect Dis; 2009 May 01; 48(9):1296-305. PubMed ID: 19331585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.